This inventor holds 1 USPTO granted patent. Top assignee: Mochida Pharmaceutical Co., Ltd.. Active years: 1997.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1997
Title: Yasunori Shibutani: Innovator in Cancer Treatment
Introduction
Yasunori Shibutani is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of cancer treatment through his innovative research and development. His work focuses on creating effective therapies that minimize side effects while maximizing therapeutic benefits.
Latest Patents
Yasunori Shibutani holds a patent for a carcinostatic for hormonotherapy containing dienogest as an effective agent. This invention is designed to exert therapeutic effects for a broad range of cancer cases at a far lower dose than that of conventional hormonotherapeutic agents. Importantly, it is expected to be free from the side effects that high-dose hormonotherapy typically suffers from.
Career Highlights
Shibutani is associated with Mochida Pharmaceutical Co., Ltd., where he continues to advance his research in cancer therapies. His dedication to improving patient outcomes through innovative treatments has positioned him as a key figure in the pharmaceutical industry.
Collaborations
He has collaborated with notable colleagues, including Masami Sato and Yukio Katsuki, to further enhance the development of effective cancer treatments.
Conclusion
Yasunori Shibutani's contributions to cancer treatment through his innovative patent demonstrate his commitment to advancing medical science. His work is paving the way for more effective and safer cancer therapies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile